Barry, OppHub America Desk · · Source: yahoo-tickers-tape-movers
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Shou
Based on reporting from yahoo-tickers-tape-movers.
Ken Griffin recently boosted stakes in AbbVie ( ABBV -0.47% ) and Abbott Laboratories ( ABT +0.14% ) , according to his latest 13F. Griffin is the billionaire founder and CEO of the hedge fund company Citadel .
Market context for this story
As of: Regular HoursLoading quotes…
Informational only — not investment advice. Full markets →
$ABTAbbott Laboratories
TradingView
Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice
Educational TradingView chart — search any symbol in the widget. Confirm on /markets/ABT and related $ABBV. Not investment advice.
Related markets
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
Ken Griffin recently boosted stakes in AbbVie ( $ABBV+WL -0.47% ) and Abbott Laboratories ( $ABT+WL +0.14% ) , according to his latest 13F. Griffin is the billionaire founder and CEO of the hedge fund company Citadel . Arguably one of the sharpest minds in the hedge-fund world, he is leaning into two healthcare machines that sit right at the intersection of science and steady cash; that's a signal worth thinking about. Griffin's portfolio holds over 1,000 positions and hundreds of billions of dollars. Yet he raised his exposure to AbbVie, a drug developer built on immunology and oncology, and Abbott, a device and diagnostics giant embedded in hospitals and homes across the globe.
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Trade this story (crypto)
Coinbase
Gemini
Robinhood
Webull
Chart this story
TradingView
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure
Story playbook
A pre-built map of what to watch — stocks, ETFs, and educational next steps. Not personalized advice.
Snapshot date: August 24, 2026 at 11:25 AM ET
This playbook was built when the story published and is not live-updated. Prices, news, and risk can change after this date — treat it as a starting map, not a current trade ticket.
Story → money map
Healthcare defensive growth
A famous billionaire investor just bought more shares of two major healthcare companies, AbbVie and Abbott Laboratories. People follow these moves because smart investors often spot safe places to put money when markets get bumpy.
What changed
Billionaire Ken Griffin's fund disclosed increased stock ownership in AbbVie and Abbott Laboratories.
Who wins / who loses
Established pharmaceutical and medical device makers benefit from defensive capital flows, while high-growth speculative sectors might see less short-term institutional attention.
Time horizon
Think in terms of the next few months.
Confidence & best fit
medium confidence · Long-term investor
Safer theme exposure (ETFs)
Baskets that own the theme without betting on one company.
Single stocks (higher risk)
Primary = closest to the story · Peers = same industry · Second-order = knock-on effects · Avoid = looks related but may be a trap
Primary
- $ABBVBuild slowly — only if it fits your plan
A top investor bought more of this major drug maker, showing faith in its steady profits and medicines.
View $ABBV chart → · End-of-day delayed data
- $ABTBuild slowly — only if it fits your plan
Buying more of this healthcare equipment giant offers reliable income from hospitals and everyday medical devices.
View $ABT chart → · End-of-day delayed data
Peer
- $JNJWatch — track, don’t rush
Another giant healthcare stock that often moves alongside AbbVie and Abbott when investors want safety.
View $JNJ chart → · End-of-day delayed data
Options (education only)
No strikes or expiries — a framework for how traders might express the view. Options can expire worthless.
Direction: bullish · Style: Covered-call income (only if you already own shares) · Level: intermediate
Beginners should skip options here; simply owning the shares for the long term is safer and avoids complex contracts.
Income / OppHub America angle
Not a trade tip — ways to use the insight outside the market.
- Look into healthcare sector mutual funds for retirement accounts
- Research individual dividend-paying medical device manufacturers
What would break this thesis
- Broad regulatory changes or major drug patent cliffs harming AbbVie or Abbott
- A aggressive rotation out of defensive sectors into high-beta tech
What to do next on OppHub America
Saved playbooks stay on this device for now.
Important
Not financial advice. OppHub America playbooks are educational market maps only — not recommendations to buy, sell, or hold any security. Markets move fast; information can be wrong or outdated. Trade and invest at your own risk. Do your own research or consult a licensed advisor.
Based on reporting from yahoo-tickers-tape-movers.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).